iScience-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2101045, encodeId=3554210104581, content=这杂志分不高还挺难，投它干嘛呀。我有一篇投过去竟然不给审稿，最终投到CD 被录用了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acf01928662, createdName=loveinpuff, createdTime=Thu Nov 17 09:51:31 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192191, encodeId=ebf521921918e, content=偏重的研究方向：分子生物学 经验分享：有人with editor已经2周了吗？等着毕业焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 06:55:43 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163953, encodeId=fc1921639539b, content=请问大家，编辑有让上传WB的整张膜的原始数据吗？如果不能提供整张膜，只有裁剪后的膜的原始数据，应该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3385731305, createdName=ms3000001607723978, createdTime=Fri Oct 20 14:01:33 CST 2023, time=2023-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127250, encodeId=ed2d212e250b3, content=大家有遇到过小修后外审很长时间的情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Thu Apr 20 14:28:42 CST 2023, time=2023-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091500, encodeId=eaf52091500d3, content=投稿后一直处于 Submitted to Journal 是什么情况，需要发邮件给每位作者确认吗求教求教！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e8485486600, createdName=ms1000001051341485, createdTime=Sun Oct 02 18:24:59 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228692, encodeId=c415122869218, content=偏重的研究方向：材料科学 经验分享：水的很，下一个science report , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=科研1995师太, createdTime=Sun Jun 26 08:26:16 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093941, encodeId=3e68209394153, content=最近从cell reports medicine 转投1篇！潜力股！前期发表1篇！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Oct 15 17:35:24 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210812, encodeId=a93b1210812cc, content=偏重的研究方向：癌症生物学 经验分享：请问有cell reports外审后拒稿转投过来的吗，还需要重新送外审嘛…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc73120115, createdName=853561971, createdTime=Wed Apr 13 10:43:49 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804558, encodeId=8a978045587c, content=iscience明年能上8么，即时IF多少了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=794a1639274, createdName=瞎猫, createdTime=Sat Jul 25 23:24:28 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2207163, encodeId=288f220e1631c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：审稿速度一般，editor处理时间较慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53699323482, createdName=ms5000000232669425, createdTime=Tue May 28 22:11:19 CST 2024, time=2024-05-28, status=1, ipAttribution=浙江省)]

2022-11-17 loveinpuff

这杂志分不高还挺难，投它干嘛呀。我有一篇投过去竟然不给审稿，最终投到CD 被录用了。

8 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2101045, encodeId=3554210104581, content=这杂志分不高还挺难，投它干嘛呀。我有一篇投过去竟然不给审稿，最终投到CD 被录用了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acf01928662, createdName=loveinpuff, createdTime=Thu Nov 17 09:51:31 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192191, encodeId=ebf521921918e, content=偏重的研究方向：分子生物学 经验分享：有人with editor已经2周了吗？等着毕业焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 06:55:43 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163953, encodeId=fc1921639539b, content=请问大家，编辑有让上传WB的整张膜的原始数据吗？如果不能提供整张膜，只有裁剪后的膜的原始数据，应该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3385731305, createdName=ms3000001607723978, createdTime=Fri Oct 20 14:01:33 CST 2023, time=2023-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127250, encodeId=ed2d212e250b3, content=大家有遇到过小修后外审很长时间的情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Thu Apr 20 14:28:42 CST 2023, time=2023-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091500, encodeId=eaf52091500d3, content=投稿后一直处于 Submitted to Journal 是什么情况，需要发邮件给每位作者确认吗求教求教！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e8485486600, createdName=ms1000001051341485, createdTime=Sun Oct 02 18:24:59 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228692, encodeId=c415122869218, content=偏重的研究方向：材料科学 经验分享：水的很，下一个science report , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=科研1995师太, createdTime=Sun Jun 26 08:26:16 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093941, encodeId=3e68209394153, content=最近从cell reports medicine 转投1篇！潜力股！前期发表1篇！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Oct 15 17:35:24 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210812, encodeId=a93b1210812cc, content=偏重的研究方向：癌症生物学 经验分享：请问有cell reports外审后拒稿转投过来的吗，还需要重新送外审嘛…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc73120115, createdName=853561971, createdTime=Wed Apr 13 10:43:49 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804558, encodeId=8a978045587c, content=iscience明年能上8么，即时IF多少了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=794a1639274, createdName=瞎猫, createdTime=Sat Jul 25 23:24:28 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2207163, encodeId=288f220e1631c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：审稿速度一般，editor处理时间较慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53699323482, createdName=ms5000000232669425, createdTime=Tue May 28 22:11:19 CST 2024, time=2024-05-28, status=1, ipAttribution=浙江省)]

2024-03-09 ms3000000526945160 来自湖北省

偏重的研究方向：分子生物学
经验分享：有人with editor已经2周了吗？等着毕业焦虑

16 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2101045, encodeId=3554210104581, content=这杂志分不高还挺难，投它干嘛呀。我有一篇投过去竟然不给审稿，最终投到CD 被录用了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acf01928662, createdName=loveinpuff, createdTime=Thu Nov 17 09:51:31 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192191, encodeId=ebf521921918e, content=偏重的研究方向：分子生物学 经验分享：有人with editor已经2周了吗？等着毕业焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 06:55:43 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163953, encodeId=fc1921639539b, content=请问大家，编辑有让上传WB的整张膜的原始数据吗？如果不能提供整张膜，只有裁剪后的膜的原始数据，应该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3385731305, createdName=ms3000001607723978, createdTime=Fri Oct 20 14:01:33 CST 2023, time=2023-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127250, encodeId=ed2d212e250b3, content=大家有遇到过小修后外审很长时间的情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Thu Apr 20 14:28:42 CST 2023, time=2023-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091500, encodeId=eaf52091500d3, content=投稿后一直处于 Submitted to Journal 是什么情况，需要发邮件给每位作者确认吗求教求教！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e8485486600, createdName=ms1000001051341485, createdTime=Sun Oct 02 18:24:59 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228692, encodeId=c415122869218, content=偏重的研究方向：材料科学 经验分享：水的很，下一个science report , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=科研1995师太, createdTime=Sun Jun 26 08:26:16 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093941, encodeId=3e68209394153, content=最近从cell reports medicine 转投1篇！潜力股！前期发表1篇！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Oct 15 17:35:24 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210812, encodeId=a93b1210812cc, content=偏重的研究方向：癌症生物学 经验分享：请问有cell reports外审后拒稿转投过来的吗，还需要重新送外审嘛…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc73120115, createdName=853561971, createdTime=Wed Apr 13 10:43:49 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804558, encodeId=8a978045587c, content=iscience明年能上8么，即时IF多少了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=794a1639274, createdName=瞎猫, createdTime=Sat Jul 25 23:24:28 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2207163, encodeId=288f220e1631c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：审稿速度一般，editor处理时间较慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53699323482, createdName=ms5000000232669425, createdTime=Tue May 28 22:11:19 CST 2024, time=2024-05-28, status=1, ipAttribution=浙江省)]

2023-10-20 ms3000001607723978 来自上海

请问大家，编辑有让上传WB的整张膜的原始数据吗？如果不能提供整张膜，只有裁剪后的膜的原始数据，应该怎么办？

36 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2101045, encodeId=3554210104581, content=这杂志分不高还挺难，投它干嘛呀。我有一篇投过去竟然不给审稿，最终投到CD 被录用了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acf01928662, createdName=loveinpuff, createdTime=Thu Nov 17 09:51:31 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192191, encodeId=ebf521921918e, content=偏重的研究方向：分子生物学 经验分享：有人with editor已经2周了吗？等着毕业焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 06:55:43 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163953, encodeId=fc1921639539b, content=请问大家，编辑有让上传WB的整张膜的原始数据吗？如果不能提供整张膜，只有裁剪后的膜的原始数据，应该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3385731305, createdName=ms3000001607723978, createdTime=Fri Oct 20 14:01:33 CST 2023, time=2023-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127250, encodeId=ed2d212e250b3, content=大家有遇到过小修后外审很长时间的情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Thu Apr 20 14:28:42 CST 2023, time=2023-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091500, encodeId=eaf52091500d3, content=投稿后一直处于 Submitted to Journal 是什么情况，需要发邮件给每位作者确认吗求教求教！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e8485486600, createdName=ms1000001051341485, createdTime=Sun Oct 02 18:24:59 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228692, encodeId=c415122869218, content=偏重的研究方向：材料科学 经验分享：水的很，下一个science report , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=科研1995师太, createdTime=Sun Jun 26 08:26:16 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093941, encodeId=3e68209394153, content=最近从cell reports medicine 转投1篇！潜力股！前期发表1篇！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Oct 15 17:35:24 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210812, encodeId=a93b1210812cc, content=偏重的研究方向：癌症生物学 经验分享：请问有cell reports外审后拒稿转投过来的吗，还需要重新送外审嘛…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc73120115, createdName=853561971, createdTime=Wed Apr 13 10:43:49 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804558, encodeId=8a978045587c, content=iscience明年能上8么，即时IF多少了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=794a1639274, createdName=瞎猫, createdTime=Sat Jul 25 23:24:28 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2207163, encodeId=288f220e1631c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：审稿速度一般，editor处理时间较慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53699323482, createdName=ms5000000232669425, createdTime=Tue May 28 22:11:19 CST 2024, time=2024-05-28, status=1, ipAttribution=浙江省)]

2023-04-20 123a6632m26暂无昵称

大家有遇到过小修后外审很长时间的情况嘛

134 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2101045, encodeId=3554210104581, content=这杂志分不高还挺难，投它干嘛呀。我有一篇投过去竟然不给审稿，最终投到CD 被录用了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acf01928662, createdName=loveinpuff, createdTime=Thu Nov 17 09:51:31 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192191, encodeId=ebf521921918e, content=偏重的研究方向：分子生物学 经验分享：有人with editor已经2周了吗？等着毕业焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 06:55:43 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163953, encodeId=fc1921639539b, content=请问大家，编辑有让上传WB的整张膜的原始数据吗？如果不能提供整张膜，只有裁剪后的膜的原始数据，应该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3385731305, createdName=ms3000001607723978, createdTime=Fri Oct 20 14:01:33 CST 2023, time=2023-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127250, encodeId=ed2d212e250b3, content=大家有遇到过小修后外审很长时间的情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Thu Apr 20 14:28:42 CST 2023, time=2023-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091500, encodeId=eaf52091500d3, content=投稿后一直处于 Submitted to Journal 是什么情况，需要发邮件给每位作者确认吗求教求教！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e8485486600, createdName=ms1000001051341485, createdTime=Sun Oct 02 18:24:59 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228692, encodeId=c415122869218, content=偏重的研究方向：材料科学 经验分享：水的很，下一个science report , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=科研1995师太, createdTime=Sun Jun 26 08:26:16 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093941, encodeId=3e68209394153, content=最近从cell reports medicine 转投1篇！潜力股！前期发表1篇！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Oct 15 17:35:24 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210812, encodeId=a93b1210812cc, content=偏重的研究方向：癌症生物学 经验分享：请问有cell reports外审后拒稿转投过来的吗，还需要重新送外审嘛…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc73120115, createdName=853561971, createdTime=Wed Apr 13 10:43:49 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804558, encodeId=8a978045587c, content=iscience明年能上8么，即时IF多少了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=794a1639274, createdName=瞎猫, createdTime=Sat Jul 25 23:24:28 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2207163, encodeId=288f220e1631c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：审稿速度一般，editor处理时间较慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53699323482, createdName=ms5000000232669425, createdTime=Tue May 28 22:11:19 CST 2024, time=2024-05-28, status=1, ipAttribution=浙江省)]

2022-10-02 ms1000001051341485

投稿后一直处于 Submitted to Journal 是什么情况，需要发邮件给每位作者确认吗求教求教！

85 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2101045, encodeId=3554210104581, content=这杂志分不高还挺难，投它干嘛呀。我有一篇投过去竟然不给审稿，最终投到CD 被录用了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acf01928662, createdName=loveinpuff, createdTime=Thu Nov 17 09:51:31 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192191, encodeId=ebf521921918e, content=偏重的研究方向：分子生物学 经验分享：有人with editor已经2周了吗？等着毕业焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 06:55:43 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163953, encodeId=fc1921639539b, content=请问大家，编辑有让上传WB的整张膜的原始数据吗？如果不能提供整张膜，只有裁剪后的膜的原始数据，应该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3385731305, createdName=ms3000001607723978, createdTime=Fri Oct 20 14:01:33 CST 2023, time=2023-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127250, encodeId=ed2d212e250b3, content=大家有遇到过小修后外审很长时间的情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Thu Apr 20 14:28:42 CST 2023, time=2023-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091500, encodeId=eaf52091500d3, content=投稿后一直处于 Submitted to Journal 是什么情况，需要发邮件给每位作者确认吗求教求教！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e8485486600, createdName=ms1000001051341485, createdTime=Sun Oct 02 18:24:59 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228692, encodeId=c415122869218, content=偏重的研究方向：材料科学 经验分享：水的很，下一个science report , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=科研1995师太, createdTime=Sun Jun 26 08:26:16 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093941, encodeId=3e68209394153, content=最近从cell reports medicine 转投1篇！潜力股！前期发表1篇！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Oct 15 17:35:24 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210812, encodeId=a93b1210812cc, content=偏重的研究方向：癌症生物学 经验分享：请问有cell reports外审后拒稿转投过来的吗，还需要重新送外审嘛…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc73120115, createdName=853561971, createdTime=Wed Apr 13 10:43:49 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804558, encodeId=8a978045587c, content=iscience明年能上8么，即时IF多少了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=794a1639274, createdName=瞎猫, createdTime=Sat Jul 25 23:24:28 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2207163, encodeId=288f220e1631c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：审稿速度一般，editor处理时间较慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53699323482, createdName=ms5000000232669425, createdTime=Tue May 28 22:11:19 CST 2024, time=2024-05-28, status=1, ipAttribution=浙江省)]

2022-06-26 科研1995师太

偏重的研究方向：材料科学
经验分享：水的很，下一个science report

150 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2101045, encodeId=3554210104581, content=这杂志分不高还挺难，投它干嘛呀。我有一篇投过去竟然不给审稿，最终投到CD 被录用了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acf01928662, createdName=loveinpuff, createdTime=Thu Nov 17 09:51:31 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192191, encodeId=ebf521921918e, content=偏重的研究方向：分子生物学 经验分享：有人with editor已经2周了吗？等着毕业焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 06:55:43 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163953, encodeId=fc1921639539b, content=请问大家，编辑有让上传WB的整张膜的原始数据吗？如果不能提供整张膜，只有裁剪后的膜的原始数据，应该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3385731305, createdName=ms3000001607723978, createdTime=Fri Oct 20 14:01:33 CST 2023, time=2023-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127250, encodeId=ed2d212e250b3, content=大家有遇到过小修后外审很长时间的情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Thu Apr 20 14:28:42 CST 2023, time=2023-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091500, encodeId=eaf52091500d3, content=投稿后一直处于 Submitted to Journal 是什么情况，需要发邮件给每位作者确认吗求教求教！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e8485486600, createdName=ms1000001051341485, createdTime=Sun Oct 02 18:24:59 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228692, encodeId=c415122869218, content=偏重的研究方向：材料科学 经验分享：水的很，下一个science report , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=科研1995师太, createdTime=Sun Jun 26 08:26:16 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093941, encodeId=3e68209394153, content=最近从cell reports medicine 转投1篇！潜力股！前期发表1篇！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Oct 15 17:35:24 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210812, encodeId=a93b1210812cc, content=偏重的研究方向：癌症生物学 经验分享：请问有cell reports外审后拒稿转投过来的吗，还需要重新送外审嘛…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc73120115, createdName=853561971, createdTime=Wed Apr 13 10:43:49 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804558, encodeId=8a978045587c, content=iscience明年能上8么，即时IF多少了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=794a1639274, createdName=瞎猫, createdTime=Sat Jul 25 23:24:28 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2207163, encodeId=288f220e1631c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：审稿速度一般，editor处理时间较慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53699323482, createdName=ms5000000232669425, createdTime=Tue May 28 22:11:19 CST 2024, time=2024-05-28, status=1, ipAttribution=浙江省)]

2022-10-15 1250d11bm60(暂无昵称)

最近从cell reports medicine 转投1篇！潜力股！前期发表1篇！

38 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2101045, encodeId=3554210104581, content=这杂志分不高还挺难，投它干嘛呀。我有一篇投过去竟然不给审稿，最终投到CD 被录用了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acf01928662, createdName=loveinpuff, createdTime=Thu Nov 17 09:51:31 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192191, encodeId=ebf521921918e, content=偏重的研究方向：分子生物学 经验分享：有人with editor已经2周了吗？等着毕业焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 06:55:43 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163953, encodeId=fc1921639539b, content=请问大家，编辑有让上传WB的整张膜的原始数据吗？如果不能提供整张膜，只有裁剪后的膜的原始数据，应该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3385731305, createdName=ms3000001607723978, createdTime=Fri Oct 20 14:01:33 CST 2023, time=2023-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127250, encodeId=ed2d212e250b3, content=大家有遇到过小修后外审很长时间的情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Thu Apr 20 14:28:42 CST 2023, time=2023-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091500, encodeId=eaf52091500d3, content=投稿后一直处于 Submitted to Journal 是什么情况，需要发邮件给每位作者确认吗求教求教！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e8485486600, createdName=ms1000001051341485, createdTime=Sun Oct 02 18:24:59 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228692, encodeId=c415122869218, content=偏重的研究方向：材料科学 经验分享：水的很，下一个science report , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=科研1995师太, createdTime=Sun Jun 26 08:26:16 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093941, encodeId=3e68209394153, content=最近从cell reports medicine 转投1篇！潜力股！前期发表1篇！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Oct 15 17:35:24 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210812, encodeId=a93b1210812cc, content=偏重的研究方向：癌症生物学 经验分享：请问有cell reports外审后拒稿转投过来的吗，还需要重新送外审嘛…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc73120115, createdName=853561971, createdTime=Wed Apr 13 10:43:49 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804558, encodeId=8a978045587c, content=iscience明年能上8么，即时IF多少了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=794a1639274, createdName=瞎猫, createdTime=Sat Jul 25 23:24:28 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2207163, encodeId=288f220e1631c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：审稿速度一般，editor处理时间较慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53699323482, createdName=ms5000000232669425, createdTime=Tue May 28 22:11:19 CST 2024, time=2024-05-28, status=1, ipAttribution=浙江省)]

2022-04-13 853561971

偏重的研究方向：癌症生物学
经验分享：请问有cell reports外审后拒稿转投过来的吗，还需要重新送外审嘛…

84 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2101045, encodeId=3554210104581, content=这杂志分不高还挺难，投它干嘛呀。我有一篇投过去竟然不给审稿，最终投到CD 被录用了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acf01928662, createdName=loveinpuff, createdTime=Thu Nov 17 09:51:31 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192191, encodeId=ebf521921918e, content=偏重的研究方向：分子生物学 经验分享：有人with editor已经2周了吗？等着毕业焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 06:55:43 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163953, encodeId=fc1921639539b, content=请问大家，编辑有让上传WB的整张膜的原始数据吗？如果不能提供整张膜，只有裁剪后的膜的原始数据，应该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3385731305, createdName=ms3000001607723978, createdTime=Fri Oct 20 14:01:33 CST 2023, time=2023-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127250, encodeId=ed2d212e250b3, content=大家有遇到过小修后外审很长时间的情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Thu Apr 20 14:28:42 CST 2023, time=2023-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091500, encodeId=eaf52091500d3, content=投稿后一直处于 Submitted to Journal 是什么情况，需要发邮件给每位作者确认吗求教求教！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e8485486600, createdName=ms1000001051341485, createdTime=Sun Oct 02 18:24:59 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228692, encodeId=c415122869218, content=偏重的研究方向：材料科学 经验分享：水的很，下一个science report , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=科研1995师太, createdTime=Sun Jun 26 08:26:16 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093941, encodeId=3e68209394153, content=最近从cell reports medicine 转投1篇！潜力股！前期发表1篇！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Oct 15 17:35:24 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210812, encodeId=a93b1210812cc, content=偏重的研究方向：癌症生物学 经验分享：请问有cell reports外审后拒稿转投过来的吗，还需要重新送外审嘛…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc73120115, createdName=853561971, createdTime=Wed Apr 13 10:43:49 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804558, encodeId=8a978045587c, content=iscience明年能上8么，即时IF多少了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=794a1639274, createdName=瞎猫, createdTime=Sat Jul 25 23:24:28 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2207163, encodeId=288f220e1631c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：审稿速度一般，editor处理时间较慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53699323482, createdName=ms5000000232669425, createdTime=Tue May 28 22:11:19 CST 2024, time=2024-05-28, status=1, ipAttribution=浙江省)]

2020-07-25 瞎猫

iscience明年能上8么，即时IF多少了？

218 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2101045, encodeId=3554210104581, content=这杂志分不高还挺难，投它干嘛呀。我有一篇投过去竟然不给审稿，最终投到CD 被录用了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acf01928662, createdName=loveinpuff, createdTime=Thu Nov 17 09:51:31 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192191, encodeId=ebf521921918e, content=偏重的研究方向：分子生物学 经验分享：有人with editor已经2周了吗？等着毕业焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 06:55:43 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163953, encodeId=fc1921639539b, content=请问大家，编辑有让上传WB的整张膜的原始数据吗？如果不能提供整张膜，只有裁剪后的膜的原始数据，应该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3385731305, createdName=ms3000001607723978, createdTime=Fri Oct 20 14:01:33 CST 2023, time=2023-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127250, encodeId=ed2d212e250b3, content=大家有遇到过小修后外审很长时间的情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Thu Apr 20 14:28:42 CST 2023, time=2023-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091500, encodeId=eaf52091500d3, content=投稿后一直处于 Submitted to Journal 是什么情况，需要发邮件给每位作者确认吗求教求教！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e8485486600, createdName=ms1000001051341485, createdTime=Sun Oct 02 18:24:59 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228692, encodeId=c415122869218, content=偏重的研究方向：材料科学 经验分享：水的很，下一个science report , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=科研1995师太, createdTime=Sun Jun 26 08:26:16 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093941, encodeId=3e68209394153, content=最近从cell reports medicine 转投1篇！潜力股！前期发表1篇！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Oct 15 17:35:24 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210812, encodeId=a93b1210812cc, content=偏重的研究方向：癌症生物学 经验分享：请问有cell reports外审后拒稿转投过来的吗，还需要重新送外审嘛…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc73120115, createdName=853561971, createdTime=Wed Apr 13 10:43:49 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804558, encodeId=8a978045587c, content=iscience明年能上8么，即时IF多少了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=794a1639274, createdName=瞎猫, createdTime=Sat Jul 25 23:24:28 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2207163, encodeId=288f220e1631c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：审稿速度一般，editor处理时间较慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53699323482, createdName=ms5000000232669425, createdTime=Tue May 28 22:11:19 CST 2024, time=2024-05-28, status=1, ipAttribution=浙江省)]

2024-05-28 ms5000000232669425 来自浙江省

审稿速度:2.0 | 投稿命中率:50.0
经验分享：审稿速度一般，editor处理时间较慢

5 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务